Compare AstraZeneca plc (AZN) vs CDW Corp. (CDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs CDW Corp. — how do they compare? AstraZeneca plc trades at $158.42 (market cap $248.14B), while CDW Corp. trades at $135.37 (market cap $16.92B). The key difference: AstraZeneca plc is far larger — about 14.7× CDW Corp.'s market cap, and AstraZeneca plc pays the higher dividend (2.01%). Which is the better fit depends on your goals.
| AZN | CDW | |
|---|---|---|
Market Cap | $248.14B | $16.92B |
Sector | Health | Technology |
52-Week High | $209.48 | $170.77 |
52-Week Low | $147.06 | $99.30 |
Enterprise Value | $275.41B | $22.52B |
Dividend Yield | 2.01% | 1.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About CDW Corp.
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →
